The iToBoS research project, funded by the European Union's Horizon 2020 research and innovation program, spans 48 months, and boasts a budget of €12 million. Recognizing the importance of the substantial backing from European funds, Canfield is deeply committed to collaborating closely with the iToBos team and distinguished thought leaders such as Dr. Josep Malvehy and Prof. Rafael Garcia. Our shared objective is to spearhead the evolution of next-generation AI Algorithms. To achieve this goal, our team is working tirelessly on this pioneering endeavor.

Our unwavering dedication to imaging excellence underscores our strict adherence to the most stringent data security standards, as well as paramount levels of privacy and confidentiality across every facet of the project. Doug Canfield, President of Canfield Scientific, expressed his sentiments, stating, “It is an honor to support important efforts in the medical dermatology field, as the impact of this initiative is far-reaching with the potential to enhance crucial screenings for millions. This collaboration exemplifies the vision of creating a healthier future by harnessing the power of cutting-edge AI technology, scientific expertise, and financial support.”

The Canfield team is honored to contribute to such impactful efforts, acknowledging the far-reaching implications of this initiative in the medical field. This partnership signifies a concerted effort to leverage cutting-edge AI technology and expertise in pursuit of a brighter and healthier tomorrow.